Ovarian cancer
Results
Phase 2
This trial looked at abiraterone for women whose ovarian cancer had come back within a year of their last treatment.
The trial was open to people who had 1 of the following cancer types:
These cancers are all treated in the same way. When we use the term ovarian cancer in this summary, we are referring to all 3.
This trial was open for people to join between 2014 and 2015. The team published the results in 2020.
Cancer Research UK supported this trial.
Recruitment start: 5 March 2014
Recruitment end: 21 December 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Susana Banerjee
Cancer Research UK
Institute of Cancer Research (ICR)
The Royal Marsden NHS Foundation Trust
Janssen-Cilag
This is a Cancer Research UK trial number CRUKE/12/052.
Last reviewed: 08 Aug 2022
CRUK internal database number: 10565
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
